Difluprednate for postop inflammation & pain

In early November, the EU MDR issued a CE mark certification for RetInSight’s AI-based geographic atrophy monitor

Moving toward eliminating drug and chemical safety testing in animals

Patients who received digital education demonstrated a better understanding of their disease and its management

At this year's American Academy of Ophthalmology meeting in San Francisco, California, Marco A. Zarbin, MD, spoke with Ophthalmology Times about his team's post-hoc analysis of the YOSEMITE and RHINE clinical trials